生達

-0.30 (-0.53%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

56.00176成交張數9.74本益比1.62股價淨值比5.36%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	123	62	24.3%	2.18	34.65	17.3%	8.6%	2.3	1.7
2026Q1	121	60	25.0%	2.05	33.81	16.6%	8.2%	3.9	3.0
2025Q4	118	61	21.3%	2.53	34.27	15.4%	8.1%	5.3	4.6
2025Q3	116	59	22.4%	2.41	33.29	15.1%	7.8%	5.1	4.8
2025Q2	116	57	25.3%	2.07	31.78	14.0%	6.9%	4.5	3.9
2025Q1	114	56	25.3%	2.08	31.40	15.1%	7.2%	2.9	1.9
2024Q4	112	59	19.7%	3.01	33.05	15.7%	7.9%	5.4	3.3
2024Q3	112	59	20.4%	2.90	33.05	15.5%	7.7%	6.8	6.5
2024Q2	118	58	26.3%	2.16	32.57	16.1%	7.4%	2.2	1.7
2024Q1	116	53	30.4%	1.91	29.66	17.8%	7.8%	2.5	1.4
2023Q4	112	53	27.3%	2.29	29.65	16.6%	7.5%	4.3	3.5
2023Q3	110	50	28.5%	2.09	28.19	17.7%	7.7%	3.6	2.7
2023Q2	112	48	33.1%	1.82	26.92	19.0%	7.8%	3.0	2.0
2023Q1	110	45	35.1%	1.70	25.39	19.8%	8.1%	2.5	0.9
2022Q4	110	48	32.2%	1.94	26.60	17.9%	7.7%	2.7	1.3
2022Q3	112	45	35.9%	1.80	25.38	18.7%	8.8%	5.0	1.6
2022Q2	108	43	37.1%	1.66	24.01	17.6%	8.1%	2.7	1.4
2022Q1	100	41	34.6%	1.93	22.76	16.2%	7.8%	2.0	1.2
2021Q4	101	43	32.7%	2.13	24.30	17.0%	8.2%	2.7	2.4
2021Q3	74	42	30.6%	2.10	23.29	17.4%	9.7%	2.7	2.3
2021Q2	74	40	32.5%	1.93	22.61	16.7%	9.1%	1.3	0.9
2021Q1	73	42	29.5%	2.20	23.77	15.7%	8.6%	1.6	1.4
2020Q4	70	40	30.4%	2.18	22.19	13.6%	7.5%	4.0	3.7
2020Q3	68	38	30.9%	2.05	21.30	12.4%	6.7%	1.5	-0.2
2020Q2	69	37	32.3%	1.94	20.96	12.5%	6.8%	2.2	1.7
2020Q1	70	36	36.5%	1.74	19.92	11.6%	6.3%	1.4	1.0
2019Q4	69	38	32.9%	1.99	21.06	10.1%	5.6%	2.5	2.1
2019Q3	69	36	37.4%	1.78	20.40	10.3%	5.7%	0.8	0.5
2019Q2	65	36	36.9%	1.76	19.90	10.8%	5.9%	1.5	1.3
2019Q1	66	37	34.8%	1.93	20.93	10.3%	5.9%	1.6	1.4
2018Q4	64	37	34.1%	1.95	20.60	10.2%	5.8%	2.5	2.2
2018Q3	63	36	34.1%	1.92	20.34	9.0%	5.2%	1.2	1.0
2018Q2	64	35	36.7%	1.74	19.85	10.3%	5.8%	-0.8	-0.9
2018Q1	63	37	32.9%	2.01	20.84	9.8%	5.9%	2.0	1.5
2017Q4	64	37	34.1%	1.92	20.55	9.8%	5.8%	1.6	1.7
2017Q3	63	37	33.4%	1.93	20.64	10.8%	6.3%	2.5	2.3
2017Q2	63	36	35.5%	1.72	20.02	9.8%	5.7%	2.0	1.9
2017Q1	61	37	30.9%	2.04	20.92	8.6%	5.3%	1.0	-1.0
2016Q4	62	37	32.6%	1.80	20.81	–	–	-0.0	-0.3
2016Q3	61	36	32.6%	1.74	20.22	–	–	-0.7	0.2